Question 1

What is the catalog number for ADS032?

Accepted Answer

The catalog number for ADS032 is M37257.

Question 2

What sizes are available for ADS032?

Accepted Answer

ADS032 is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does ADS032 come in?

Accepted Answer

ADS032 is available in 7 different pack sizes.

Question 4

Is ADS032 in stock?

Accepted Answer

ADS032 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is ADS032 used for?

Accepted Answer

ADS032 (BT-032) is an NLRP1 and NLRP3 inhibitor with anti-inflammatory activity, , inhibits the activation of NLRP1 and NLRP3, inhibits Nigericin-induced IL-1β production, and can be used to study respiratory inflammation or infection.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 7

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 8

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

ADS032

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

SEC14L1 (SEC14-like Protein 1, SEC14-like 1 (S. Cerevisiae) )

MRPL24 siRNA (Mouse)

MRPL24 siRNA (Mouse)

MRPL24 siRNA (Mouse)

Anti-Human CPB2 Nanobody

Anti-Human CPB2 Nanobody